Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026)

Intuitive Surgical (ISRG) recorded quarterly Cash from Investing Activities of -$914.5 million in Q1 2026, down 336.72% quarter-over-quarter from -$209.4 million in Q4 2025, and down 528.34% on a YoY basis from $213.5 million in Q1 2025.

Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Intuitive Surgical's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$914.5 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 528.34% year-over-year to -$914.5 million; the TTM figure through Mar 2026 stood at -$462.2 million (up 84.23% YoY), while the FY2025 annual figure was $665.8 million, up 120.34% from the prior year.
  • Cash from Investing Activities was -$914.5 million for Q1 2026 at Intuitive Surgical, down from -$209.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $574.8 million in Q4 2022 to a low of -$1.4 billion in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$147.7 million across 5 years, with a median of -$128.5 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities surged 366.93% in 2023, then slumped 528.34% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at $574.8 million in 2022, then plunged by 281.66% to -$1.0 billion in 2023, then declined by 21.07% to -$1.3 billion in 2024, then soared by 83.44% to -$209.4 million in 2025, then sank by 336.72% to -$914.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$914.5 million (Q1 2026), -$209.4 million (Q4 2025), and $401.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -65.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -914.50 Mn
Mar 31, 2026 -914.50 Mn
Dec 31, 2025 -209.40 Mn
Dec 31, 2025 -209.40 Mn
Sep 30, 2025 401.00 Mn
Sep 30, 2025 401.00 Mn
Jun 30, 2025 260.70 Mn
Jun 30, 2025 260.70 Mn
Mar 31, 2025 213.50 Mn
Mar 31, 2025 213.50 Mn
Dec 31, 2024 -1.26 Bn
Dec 31, 2024 -1.26 Bn
Sep 30, 2024 -1.41 Bn
Sep 30, 2024 -1.41 Bn
Jun 30, 2024 -467.10 Mn
Jun 30, 2024 -467.10 Mn
Mar 31, 2024 -128.50 Mn
Mar 31, 2024 -128.50 Mn
Dec 31, 2023 -1.04 Bn
Dec 31, 2023 -1.04 Bn